BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19499208)

  • 1. Transport advances in disposable bioreactors for liver tissue engineering.
    Catapano G; Patzer JF; Gerlach JC
    Adv Biochem Eng Biotechnol; 2009; 115():117-43. PubMed ID: 19499208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs.
    Weng J; Han X; Zeng F; Zhang Y; Feng L; Cai L; Liang K; Liu S; Li S; Fu G; Zeng M; Gao Y
    Theranostics; 2021; 11(16):7620-7639. PubMed ID: 34335954
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioartificial livers: a review of their design and manufacture.
    Tuerxun K; He J; Ibrahim I; Yusupu Z; Yasheng A; Xu Q; Tang R; Aikebaier A; Wu Y; Tuerdi M; Nijiati M; Zou X; Xu T
    Biofabrication; 2022 Jun; 14(3):. PubMed ID: 35545058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver.
    Nibourg GA; Boer JD; van der Hoeven TV; Ackermans MT; van Gulik TM; Chamuleau RA; Hoekstra R
    Biotechnol Bioeng; 2012 Dec; 109(12):3182-8. PubMed ID: 22729831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
    van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
    J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
    Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
    J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
    van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial and bioartificial liver support.
    McKenzie TJ; Lillegard JB; Nyberg SL
    Semin Liver Dis; 2008 May; 28(2):210-7. PubMed ID: 18452120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal tissue engineered liver-assist devices.
    Tzanakakis ES; Hess DJ; Sielaff TD; Hu WS
    Annu Rev Biomed Eng; 2000; 2():607-32. PubMed ID: 11701525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes.
    Shi XL; Gao Y; Yan Y; Ma H; Sun L; Huang P; Ni X; Zhang L; Zhao X; Ren H; Hu D; Zhou Y; Tian F; Ji Y; Cheng X; Pan G; Ding YT; Hui L
    Cell Res; 2016 Feb; 26(2):206-16. PubMed ID: 26768767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver support therapy: an overview of the AMC-bioartificial liver research.
    van de Kerkhove MP; Poyck PP; Deurholt T; Hoekstra R; Chamuleau RA; van Gulik TM
    Dig Surg; 2005; 22(4):254-64. PubMed ID: 16174982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
    Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
    Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of porcine hepatocytes in three-dimensional bioreactor at room temperature using epigallocatechin-3-gallate.
    Miskon A; Yamaoka T; Hyon SH; Kodama M; Uyama H
    Tissue Eng Part C Methods; 2009 Sep; 15(3):345-53. PubMed ID: 19196126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioartificial liver: its pros and cons.
    Chamuleau RA; Poyck PP; van de Kerkhove MP
    Ther Apher Dial; 2006 Apr; 10(2):168-74. PubMed ID: 16684219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioartificial liver--state of the art.
    Strain AJ; Neuberger JM
    Science; 2002 Feb; 295(5557):1005-9. PubMed ID: 11834813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioengineering of liver assist devices.
    Tilles AW; Berthiaume F; Yarmush ML; Tompkins RG; Toner M
    J Hepatobiliary Pancreat Surg; 2002; 9(6):686-96. PubMed ID: 12658402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioartificial liver systems: why, what, whither?
    Gerlach JC; Zeilinger K; Patzer Ii JF
    Regen Med; 2008 Jul; 3(4):575-95. PubMed ID: 18588477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of disposable bag bioreactors in tissue engineering and for the production of therapeutic agents.
    Eibl R; Eibl D
    Adv Biochem Eng Biotechnol; 2009; 112():183-207. PubMed ID: 19290502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic tissue engineering.
    Kulig KM; Vacanti JP
    Transpl Immunol; 2004 Apr; 12(3-4):303-10. PubMed ID: 15157923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure.
    Zhang Z; Zhao YC; Cheng Y; Jian GD; Pan MX; Gao Y
    World J Gastroenterol; 2014 Dec; 20(46):17399-406. PubMed ID: 25516651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.